Journal Profile | |
Journal Title | Molecular Neurodegeneration
|
Journal Title Abbreviations | MOL NEURODEGENER |
ISSN | 1750-1326 |
h-index | 66 |
CiteScore | CiteScore | SJR | SNIP | CiteScore Rank |
---|
15.00 | 4.040 | 1.671 | Subject field | Quartiles | Rank | Percentile | Category: Neuroscience Subcategory: Cellular and Molecular Neuroscience | Q1 | 5 / 84 |
| Category: Neuroscience Subcategory: Molecular Biology | Q1 | 24 / 381 |
| Category: Neuroscience Subcategory: Neurology (clinical) | Q1 | 10 / 348 |
|
|
|
Self-Citation Ratio (2019-2020) | 1.60% |
Official Website | https://www.springer.com/journal/13024 |
Online Manuscript Submission | https://www.editorialmanager.com/MOND |
Open Access | Yes |
Publisher | BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL |
Subject Area | Medicine |
Country/Area of Publication | ENGLAND |
Publication Frequency | Monthly |
Year Publication Started | 2006 |
Annual Article Volume | 47 |
Indexing (SCI or SCIE) | Science Citation Index Expanded
|
Link to PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1750-1326%5BISSN%5D |
Average Duration of Peer Review * | Authorized Data from Publisher: Data from Authors: Slow, 6-12 Week(s) |
Competitiveness * | Data from Authors: |
Useful Links | |
*All review process metrics, such as acceptance rate and review speed, are limited to our user-submitted manuscripts. As such they may not reflect the journals' exact competitiveness or speed. |